1. Seasonal influenza activity in the United States remains low.
2. In clinical labs, 0.1% of respiratory specimens tested positive for influenza.
3. In public health labs, few specimens tested positive for influenza.
4. Influenza virus characterization information will be reported later in the season.
5. Outpatient visits for influenza-like illness (ILI) accounted for 1.8% of healthcare visits, below the national baseline of 2.5%.
6. ILI activity varied by region, but overall influenza virus circulation remains low.
7. Long-term care facilities reported a small percentage of influenza-positive tests among residents.
8. Hospitalization rates and pediatric deaths due to influenza are not yet reported for the current season.
9. Mortality surveillance showed that 16.5% of deaths were attributed to pneumonia, influenza, or COVID-19, above the epidemic threshold.
10. No influenza-associated pediatric deaths have been reported for the current season.
11. Vaccination and antiviral drugs are recommended for preventing and treating influenza.
12. Virologic surveillance, outpatient illness surveillance, hospitalization surveillance, and mortality surveillance are crucial components of predicting future influenza occurrence.
13. Additional national and international influenza surveillance information is available through various organizations and agencies.